LQDANCMHealthcare·Drug Manufacturers - Specialty & Generic#16 in industry

Liquidia Corporation

Reports in 10d· 2026-05-07

-12.1% · 90d

$37.34

+0.03 (+0.08%)

After-Hours $37.44(+0.10)

News

No News Yet

Press releases and SEC filings for LQDA will appear here as they are published.

Check back later for updates

Key Data

Market Cap$3.29B

Open$37.47

Prev Close$37.31

Day Range$36.95 – $38.41

52W Range$11.85 – $46.67

Volume777,274

P/E (TTM)—

EPS$-0.80

Dividend Yield—

Beta0.46

Profit Margin-43.54%

Revenue Growth3054.60%

Price Target$50.67(+35.7%)

Next Earnings2026-05-07(10d)

Analyst Ratings

Strong Buy9 analysts

Buy 8Hold 0Sell 1

About

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Healthcare · Drug Manufacturers - Specialty & Generic

216 employees

www.liquidia.com